HOLX
HOLOGIC INCPrice
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells since Apr 7. Recent filings are awards, exercises and tax withholding.
- InstitutionsBEARISH
Q2 2026: 0 added (0 new), 92 trimmed or exited.
- EstimatesFALLING
Current-quarter EPS estimate $1.099 → $1.069 over 90 days. 0 up, 4 down in 30 days.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| HUNTINGTON NATIONAL BANK | NEAR_EXIT | Not reported |
| PRICE T ROWE ASSOCIATES INC /MD/ | EXIT | $0.00 |
| CITADEL ADVISORS LLC | EXIT | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | EXIT | $0.00 |
| JPMORGAN CHASE & CO | EXIT | $0.00 |
| DIMENSIONAL FUND ADVISORS LP | EXIT | $0.00 |
| BANK OF MONTREAL /CAN/ | EXIT | $0.00 |
| FMR LLC | EXIT | $0.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Jan 2026| Date | Firm | Rating |
|---|---|---|
| Jan 12, 2026 | Argus Research DOWNGRADE | Hold |
| Jan 5, 2026 | Evercore ISI Group DOWNGRADE | In-Line |
| Nov 11, 2025 | Morgan Stanley MAINTAIN | Equal-Weight |
| Oct 23, 2025 | Mizuho DOWNGRADE | Neutral |
| Oct 22, 2025 | Raymond James DOWNGRADE | Market Perform |
| Oct 22, 2025 | Stephens & Co. DOWNGRADE | Equal-Weight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Mitchell Essex D Chief Operating Officer Apr 7, 2026 | TO ISSUER | 77,694 sh |
Mitchell Essex D Chief Operating Officer Apr 7, 2026 | TO ISSUER | 2,972 sh |
Oberton Karleen Marie Chief Financial Officer Apr 7, 2026 | TO ISSUER | 23,775 sh |
Schnittker Brandon President, GYN Surgical Apr 7, 2026 | TO ISSUER | 2,538 sh |
Liddy Anne M. General Counsel Apr 7, 2026 | TO ISSUER | 6,129 sh |
Mitchell Essex D Chief Operating Officer Apr 7, 2026 | AWARD | 46,154 sh |
MACMILLAN STEPHEN P Chairman, President and CEO Apr 7, 2026 | TO ISSUER | 160,565 sh |
Mitchell Essex D Chief Operating Officer Apr 7, 2026 | TO ISSUER | 46,154 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Next FY | $3.78 | $3.05–$4.39 | +0.0% | $4.5B |
| Current FY | $4.46 | $4.35–$4.64 | +0.8% | $4.2B |
| Current Q | $1.07 | $1.01–$1.14 | +1.4% | $1.0B |
| Next Q | $1.12 | $1.09–$1.18 | +1.3% | $1.1B |
Washington
SecBot reports
5 filings · 0 bullish · 0 bearish · 1 mixed · 4 neutral- NEUTRAL 15-12GApr 17, 2026
Hologic, Inc. has filed Form 15-12G to terminate its SEC registration and suspend reporting…
Traders should note that HOLX shares will likely cease trading on Nasdaq and may move to OTC markets, reducing liquidity and access to financial disclosures. Existing shareholders should evaluate…
- NEUTRAL EFFECTApr 13, 2026
Hologic Inc. has two shelf registration statements (File Nos. 333-73596 and 033-65019) that became…
Traders should monitor for future 424B filings or press releases that may disclose specific terms of any securities offering under these shelf registrations. The effectiveness itself is…
- NEUTRAL 8-KApr 7, 2026
Hologic completed its acquisition by Blackstone and TPG, becoming a private company. The deal…
Traders should note that Hologic is no longer publicly traded, eliminating liquidity for existing shareholders. The CVR provides potential upside based on future revenue performance, but investors…
- NEUTRAL 8-KApr 6, 2026
Hologic CEO Stephen MacMillan announced his retirement effective upon the closing of the company's…
The stock will likely be delisted following the closing on April 7, 2026. Traders should position accordingly as the company transitions to private ownership. The retirement of the long-tenured CEO…
All HOLX filing & press-release reports (5)
- 15-12G reportApr 17, 2026
- EFFECT reportApr 13, 2026
- 8-K reportApr 7, 2026
- 8-K reportApr 6, 2026
- INST-CLUSTER reportFeb 28, 2026